MyoVista wavECG vs Isabel Healthcare
HeartSciences has no AI-ECG product on sale. FDA cleared its MyoVista wavECG on October 5, 2026 under K260005 without an AI-ECG algorithm, and the company says it does not intend to commercialize the device without a cleared one. It gives no timeline, so a group that wants AI-assisted ECG reads has nothing to order from it.
Isabel's price is public. Standard is $149 per year after a 30-day free trial, Premium is $199 per year and adds an English-only LLM layer, and students and residents pay $49 per year. Institutions request a demo and get no published price. Its input is demographics plus free-text findings, and it returns a ranked differential with red-flag diagnoses for an internist. The vendor says DDx Companion is in the Cerner App Gallery, gives Epic clients info-button access, and has had an API since 2010.
Decision support · Reviewed November 2, 2026
MyoVista wavECG
by HeartSciences
12-lead resting ECG device for cardiology clinics, FDA 510(k) cleared in October 2026 without its AI-ECG algorithm.
Isabel Healthcare
by Isabel Healthcare · founded 1999
Differential-diagnosis generator with self-triage and educator products. The vendor says it is used in over 90 countries and 14 languages.
When to pick each one
MyoVista wavECG
- Homepage links an Epic showroom listing
- K260005 clears the wavECG device without AI
Isabel Healthcare
- Standard $149 per year after 30-day trial
- Premium $199 per year adds English-only LLM layer
- Vendor says Cerner App Gallery and Epic info-button access
Score
Each row shows points earned of points available under the published rubric.
MyoVista wavECG
31of 100
Isabel Healthcare
35of 100
| Dimension | MyoVista wavECG | Isabel Healthcare | Difference |
|---|---|---|---|
| FDA clearance | 12 / 12 | 0 / 12 | +12 |
| HIPAA / SOC2 / BAA | 6 / 10 | 0 / 10 | +6 |
| EHR integrations (count) | 1.7 / 5.6 | 0 / 5.6 | +1.7 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 1.9 / 4.8 | 0 / 4.8 | +1.9 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 0 / 21 | 14.7 / 21 | -14.7 |
| RCT / meta-analysis / systematic review | 0 / 9 | 0 / 9 | 0 |
| Funding & adoption signal | 3 / 12 | 6 / 12 | -3 |
| Pricing transparency | 1.3 / 2.5 | 2.5 / 2.5 | -1.2 |
| Years in market | 0 / 6 | 6 / 6 | -6 |
Scroll horizontally to see every column.
Pricing
MyoVista wavECG
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Isabel Healthcare
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Standard | n/a | $149 | EUR 139 incl. VAT. 30-day free trial. |
| Premium | n/a | $199 | EUR 179 incl. VAT. Adds an LLM layer (English only). |
| Student / resident | n/a | $49 | Not available to EU students. 50% discount for listed emerging economies. |
| Institutional | n/a | n/a | Demo request, no public price. The API has been available since 2010. |
Evidence
MyoVista wavECG
FDA decisions
K260005 (opens in new tab)510(k)2026-10-05
MyoVista wavECG (DG-200-B15-003)
Isabel Healthcare
FDA decisions
No FDA decision cited in our research as of October 20, 2026.
Peer-reviewed
2 PubMed records name Isabel Healthcare.
- Cracking the code: a head-to-head comparison of expert clinicians and artificial intelligence in diagnosing rare diseases. (opens in new tab)
- Is language an issue? Accuracy of the German computerized diagnostic decision support system ISABEL and cross-validation with the English counterpart. (opens in new tab)
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | MyoVista wavECG | Isabel Healthcare |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Epic | Not specified |
| Founded | n/a | 1999 |
| HQ | US | UK |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.